Adlai Nortye (NASDAQ:ANL) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Adlai Nortye (NASDAQ:ANL) announced its quarterly earnings data on Friday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.06, FiscalAI reports. The company had revenue of $6.53 million during the quarter, compared to analyst estimates of $7.33 million.

Adlai Nortye Trading Up 3.0%

Shares of ANL stock opened at $13.25 on Friday. Adlai Nortye has a 12 month low of $0.88 and a 12 month high of $17.25. The firm has a fifty day moving average price of $11.43 and a 200 day moving average price of $10.76.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ANL. Cantor Fitzgerald initiated coverage on Adlai Nortye in a report on Monday, June 22nd. They set an “overweight” rating on the stock. Oppenheimer began coverage on Adlai Nortye in a research note on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price objective for the company. JonesTrading initiated coverage on Adlai Nortye in a research report on Thursday, May 14th. They set a “buy” rating and a $22.00 price objective for the company. HC Wainwright upped their target price on shares of Adlai Nortye from $16.00 to $20.00 and gave the stock a “buy” rating in a research note on Monday, April 20th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Five equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $24.25.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.